Home
Morningside Pharmaceuticals

六月 2026的Morningside Pharmaceuticals市场份额分析

"making quality healthcare an affordable and accessible reality throughout the world" we are morningside our work celebrating 30 yearsmorningside ...

健康 > 生物科技及制药

域morningsidepharm.com

成立年份1991

员工51 - 200

年营收$100M - $200M

Morningside Pharmaceuticals

Morningside Pharmaceuticals（包含公司地区分支机构）

morningsidepharm.com

查看更多网站流量和参与度信息

Morningside Pharmaceuticals收入截至六月 2026为 100M - 200M

Morningside Pharmaceuticals主要域名产生的收入

3 年中Morningside Pharmaceuticals主要域名的收入

Morningside Pharmaceuticals主要域名的收入

morningsidepharm.com100M - 200M

使用销售情报查看更多信息

Morningside Pharmaceuticals热门域名的总访问量

了解Morningside Pharmaceuticals市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

无数据可显示

Morningside Pharmaceuticals热门域名的平均访问时长

分析Morningside Pharmaceuticals参与度指标。

过去 3 个月的平均访问时长

无数据可显示

Morningside Pharmaceuticals热门域名的平均页面浏览量

了解Morningside Pharmaceuticals如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

无数据可显示

Morningside Pharmaceuticals 排名靠前的竞争对手（按域名）

六月 2026的热门相似网站，按亲和力排名

united-drug.com公司名称United Drug plc员工501 - 1000总部爱尔兰, Dublin年营收$10M - $15M总访问量4.6K健康 > 生物科技及制药

Morningside Pharmaceuticals 采用的主要技术

这些是排名前 Morningside Pharmaceuticals 的顶级域名所使用的网站技术（按行业分列）

小部件 (6)

Twemoji

付费广告 (3)

DoubleClick

电子邮件服务 (3)

Microsoft Exchange Online

视听媒体 (2)

YouTube

更多技术

7

查看全部

Morningside Pharmaceuticals 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Aspire Medical Centre Benowa acquired Morningside Pharmaceuticals Ltd. on Jan 1st '22.Since 2016, the medical centre has been sponsored by Loughborough-based Morningside Pharmaceuticals, which was acquired by Aspire in 2022.

新闻Aspire Pharma Limited acquired Morningside Pharmaceuticals Ltd. for $50B on Oct 3rd '22.H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that its portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals (together “Morningside” or the “Company”), a leading UK provider of niche generic and branded specialty pharmaceuticals.

新闻Morningside Pharmaceuticals Ltd. receives award Investment Award at 2021 East Midlands Business Masters Awards.“Morningside was delighted to win the Investment Award at the 2021 East Midlands Business Masters Awards, as the company has a rich history of innovation and investing in research & development and continuous improvement, which stretches back more than 30 years.

六月 2026的Morningside Pharmaceuticals市场份额分析

Morningside Pharmaceuticals收入截至 六月 2026为 100M - 200M

3 年中Morningside Pharmaceuticals主要域名的收入

Morningside Pharmaceuticals主要域名的收入

Morningside Pharmaceuticals热门域名的总访问量

过去 3 个月的总访问量

Morningside Pharmaceuticals热门域名的平均访问时长

过去 3 个月的平均访问时长

Morningside Pharmaceuticals热门域名的平均页面浏览量

过去 3 个月的平均页面浏览量

Morningside Pharmaceuticals 排名靠前的竞争对手（按域名）

Morningside Pharmaceuticals 采用的主要技术

小部件 (6)

付费广告 (3)

电子邮件服务 (3)

视听媒体 (2)

Morningside Pharmaceuticals 的新闻与信号

Morningside Pharmaceuticals收入截至六月 2026为 100M - 200M